PL2776431T3 - Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diylu - Google Patents
Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diyluInfo
- Publication number
- PL2776431T3 PL2776431T3 PL12791863.9T PL12791863T PL2776431T3 PL 2776431 T3 PL2776431 T3 PL 2776431T3 PL 12791863 T PL12791863 T PL 12791863T PL 2776431 T3 PL2776431 T3 PL 2776431T3
- Authority
- PL
- Poland
- Prior art keywords
- oxazolidin
- diyl
- oxo
- antibiotic derivatives
- antibiotic
- Prior art date
Links
- -1 2-oxo-oxazolidin-3,5-diyl Chemical group 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2011054968 | 2011-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2776431T3 true PL2776431T3 (pl) | 2016-11-30 |
Family
ID=47258051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12791863.9T PL2776431T3 (pl) | 2011-11-08 | 2012-11-07 | Stanowiące antybiotyki pochodne 2-okso-oksazolidyno-3,5-diylu |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9079922B2 (2) |
| EP (1) | EP2776431B1 (2) |
| JP (1) | JP6030146B2 (2) |
| KR (1) | KR20140096337A (2) |
| AR (1) | AR088691A1 (2) |
| AU (1) | AU2012335207B2 (2) |
| BR (1) | BR112014011064A8 (2) |
| CA (1) | CA2854264A1 (2) |
| CL (1) | CL2014001154A1 (2) |
| ES (1) | ES2581056T3 (2) |
| HK (1) | HK1202288A1 (2) |
| IL (1) | IL232463A0 (2) |
| IN (1) | IN2014CN04126A (2) |
| MX (1) | MX344529B (2) |
| PH (1) | PH12014500831A1 (2) |
| PL (1) | PL2776431T3 (2) |
| RU (1) | RU2616609C2 (2) |
| SG (1) | SG11201401710PA (2) |
| TW (1) | TWI594996B (2) |
| WO (1) | WO2013068948A1 (2) |
| ZA (1) | ZA201404176B (2) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0920895A8 (pt) | 2008-10-07 | 2017-12-26 | Actelion Pharmaceuticals Ltd | Compostos antibióticos de oxazolidinona tricíclica |
| PL2986607T3 (pl) | 2013-04-16 | 2017-11-30 | Idorsia Pharmaceuticals Ltd | Przeciwbakteryjne pochodne biaromatyczne |
| AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
| MA41169A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| EA201891654A1 (ru) * | 2016-02-08 | 2019-01-31 | РЭДКС ФАРМА ПиЭлСи | Антибактериальные соединения |
| WO2017137743A1 (en) * | 2016-02-08 | 2017-08-17 | Redx Pharma Plc | Antibacterial compounds |
| GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
| BR112018075297A2 (pt) | 2016-06-08 | 2019-03-19 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A | composto, composição farmacêutica, e, método para tratar uma infecção bacteriana |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| PL3634968T3 (pl) | 2017-06-08 | 2023-07-31 | Bugworks Research, Inc. | Związki heterocykliczne użyteczne jako środki przeciwbakteryjne oraz sposób ich wytwarzania |
| WO2019106693A1 (en) * | 2017-11-29 | 2019-06-06 | Bugworks Research India Pvt Ltd | Anti-bacterial heterocyclic compounds and their synthesis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149104A (en) | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
| HU168497B (2) | 1972-12-18 | 1976-05-28 | ||
| SE444566B (sv) | 1977-09-20 | 1986-04-21 | Bellon Labor Sa Roger | 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav |
| GB1598915A (en) | 1977-09-20 | 1981-09-23 | Bellon Labor Sa Roger | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them |
| CS274601B2 (en) | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
| JPS62205060A (ja) | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | ８位置換キノロンカルボン酸誘導体 |
| DK164287A (da) | 1986-03-31 | 1987-10-01 | Sankyo Co | Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse |
| JP2631854B2 (ja) | 1987-12-23 | 1997-07-16 | 藤本製薬株式会社 | 新規な１，８−ナフチリジン誘導体 |
| DE4301246A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| US20050215801A1 (en) | 2002-06-28 | 2005-09-29 | Kumi Kitajima | Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for synthesis thereof and process for preparation of the intermediates |
| NZ543757A (en) * | 2003-04-30 | 2009-02-28 | Morphochem Ag Komb Chemie | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| AU2004299278C9 (en) * | 2003-12-18 | 2013-10-24 | Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| EP1771456A2 (fr) | 2004-07-30 | 2007-04-11 | Palumed SA | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| AU2005279611A1 (en) | 2004-09-01 | 2006-03-09 | Ubitrak Inc. | System for gaming chip identification and counting |
| US20090156577A1 (en) | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| EP2007377A4 (en) | 2006-04-06 | 2011-08-17 | Glaxo Group Ltd | ANTIBACTERIAL ACTIVE SUBSTANCES |
| RU2453546C2 (ru) * | 2006-11-10 | 2012-06-20 | Актелион Фармасьютиклз Лтд | Производные 5-гидроксиметилоксазолидин-2-она |
| CL2008001003A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| CL2008001002A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| ES2380398T3 (es) * | 2007-12-18 | 2012-05-11 | Actelion Pharmaceuticals Ltd. | Derivados 5-aminociclilmetil-oxazolidin-2-ona |
| RU2501799C2 (ru) * | 2008-02-22 | 2013-12-20 | Актелион Фармасьютикалз Лтд | Поизводные оксазолидинона |
| BRPI0920895A8 (pt) | 2008-10-07 | 2017-12-26 | Actelion Pharmaceuticals Ltd | Compostos antibióticos de oxazolidinona tricíclica |
| WO2010041219A1 (en) * | 2008-10-10 | 2010-04-15 | Actelion Pharmaceuticals Ltd | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| KR101667066B1 (ko) | 2008-10-10 | 2016-10-17 | 액테리온 파마슈티칼 리미티드 | 옥사졸리디닐 항생제 |
| TW201121965A (en) | 2009-09-28 | 2011-07-01 | Lg Life Sciences Ltd | Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
| CN101792443A (zh) | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
-
2012
- 2012-11-07 IN IN4126CHN2014 patent/IN2014CN04126A/en unknown
- 2012-11-07 EP EP12791863.9A patent/EP2776431B1/en not_active Not-in-force
- 2012-11-07 AU AU2012335207A patent/AU2012335207B2/en not_active Ceased
- 2012-11-07 PL PL12791863.9T patent/PL2776431T3/pl unknown
- 2012-11-07 ES ES12791863.9T patent/ES2581056T3/es active Active
- 2012-11-07 SG SG11201401710PA patent/SG11201401710PA/en unknown
- 2012-11-07 JP JP2014540612A patent/JP6030146B2/ja not_active Expired - Fee Related
- 2012-11-07 RU RU2014123109A patent/RU2616609C2/ru not_active IP Right Cessation
- 2012-11-07 AR ARP120104192A patent/AR088691A1/es unknown
- 2012-11-07 TW TW101141423A patent/TWI594996B/zh not_active IP Right Cessation
- 2012-11-07 BR BR112014011064A patent/BR112014011064A8/pt not_active Application Discontinuation
- 2012-11-07 PH PH1/2014/500831A patent/PH12014500831A1/en unknown
- 2012-11-07 WO PCT/IB2012/056236 patent/WO2013068948A1/en not_active Ceased
- 2012-11-07 MX MX2014005637A patent/MX344529B/es active IP Right Grant
- 2012-11-07 KR KR1020147014957A patent/KR20140096337A/ko not_active Abandoned
- 2012-11-07 CA CA2854264A patent/CA2854264A1/en not_active Abandoned
- 2012-11-07 HK HK15102622.5A patent/HK1202288A1/xx unknown
- 2012-11-07 US US14/356,896 patent/US9079922B2/en not_active Expired - Fee Related
-
2014
- 2014-04-30 CL CL2014001154A patent/CL2014001154A1/es unknown
- 2014-05-05 IL IL232463A patent/IL232463A0/en unknown
- 2014-06-06 ZA ZA2014/04176A patent/ZA201404176B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201326166A (zh) | 2013-07-01 |
| HK1202288A1 (en) | 2015-09-25 |
| CN103917539A (zh) | 2014-07-09 |
| PH12014500831A1 (en) | 2019-08-07 |
| RU2616609C2 (ru) | 2017-04-18 |
| KR20140096337A (ko) | 2014-08-05 |
| BR112014011064A8 (pt) | 2017-12-26 |
| US9079922B2 (en) | 2015-07-14 |
| AR088691A1 (es) | 2014-06-25 |
| RU2014123109A (ru) | 2015-12-20 |
| AU2012335207B2 (en) | 2017-05-25 |
| IL232463A0 (en) | 2014-06-30 |
| BR112014011064A2 (pt) | 2017-06-13 |
| IN2014CN04126A (2) | 2015-07-10 |
| JP6030146B2 (ja) | 2016-11-24 |
| TWI594996B (zh) | 2017-08-11 |
| JP2014532754A (ja) | 2014-12-08 |
| ES2581056T3 (es) | 2016-08-31 |
| SG11201401710PA (en) | 2014-09-26 |
| EP2776431A1 (en) | 2014-09-17 |
| CL2014001154A1 (es) | 2014-09-12 |
| WO2013068948A1 (en) | 2013-05-16 |
| MX344529B (es) | 2016-12-19 |
| EP2776431B1 (en) | 2016-05-04 |
| CA2854264A1 (en) | 2013-05-16 |
| ZA201404176B (en) | 2016-05-25 |
| MX2014005637A (es) | 2014-06-23 |
| AU2012335207A1 (en) | 2014-07-03 |
| US20150051188A1 (en) | 2015-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201404176B (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives | |
| SG10201601802YA (en) | Dispiropyrrolidine derivatives | |
| EP2753642B8 (en) | Glp-1 derivatives | |
| ZA201401884B (en) | New dihydroquinoline-2-one derivatives | |
| ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
| AP2013007043A0 (en) | Novel heterocyclic derivatives | |
| SG11201401937YA (en) | New aryl-quinoline derivatives | |
| IL247640A0 (en) | History of heteroaryl piperidine | |
| ZA201404074B (en) | 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives | |
| ZA201401852B (en) | Aniline derivatives,their therapeutic application | |
| ZA201306229B (en) | Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines | |
| ZA201302112B (en) | 1,4-oxazepane derivatives | |
| IL233001A0 (en) | New iso-ergoline histories | |
| SI2766342T1 (sl) | Derivati fenil-gvanidina | |
| ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
| ZA201209319B (en) | Cyclopropyl-indole derivatives | |
| GB201119592D0 (en) | Novel heteroaromatic Derivatives I | |
| GB201119961D0 (en) | Antibacterial derivatives | |
| GB201119958D0 (en) | Antibacterial derivatives | |
| HK1188994A (en) | Novel heterocyclic derivatives | |
| GB201119594D0 (en) | Novel heteroaromatic derivatives II | |
| AU2011901326A0 (en) | Improved lagging | |
| HK1186730A (en) | 1,4-oxazepane derivatives |